<p>FBA/SPPLs co-transfected HEK cells were treated with DMSO or GSIs as appropriate. Twenty-four hours later the medium was collected for assay by Aβ ELISA. xAβ<sub>1-25/K16A</sub> levels from DMSO-treated cells served as the control. All tests were repeated 3 times. Data were analyzed using GraphPad.</p
<p><b>A, Top,</b> Left panel: Cell survival of Rink-1 cells treated with GSI. Cells treated with GSI...
<p>(<b>A</b>), SCC1 and OSC19 cells were treated with varying concentrations of GSPs (0, 20, 40 and ...
<p>(A) Immunofluorescence analysis of PAX-7 (green) and DAPI (blue) expression in primary satellite ...
<p>Cells were transiently transfected with GSK3-β (S9A), GSK3-β (K85) and pCDNA3.1 as Mock using Fug...
<p><b>A</b>, Proliferation of RD and KYM-1 cells treated with GSI X or equal volume of DMSO vehicle ...
<p>(A-B) IFNγ-primed BMMs were pre-treated with vehicle control DMSO or GSI (25 μM) for 30 min and a...
<p><i>A</i>, BT474 (left) and LNCaP (right) cell lines were treated with DMSO or GSK2110183 for 1 h....
A. Representative western blot of U937 cells treated for 24 hours with the indicated TKIs. B. Quanti...
<p>(A) Wound recovery of U251 and U87 cells in the presence of indicated agents. ** <i>P</i><0.01 ve...
<p>(A) Transduced Ba/F3 cells were treated with DMSO (0.1%) or the indicated concentrations of GSK-3...
<p>Each assay was repeated at least 3 times. The values in the table are the means ± standard errors...
<p>(<b>A</b>), Treatment of HNSCC cells (SCC1, OSC19, FaDu and SCC5) with GSPs for 24 and 48 h inhib...
<p>A. Design of SPP assay substrate based on BRI2 transmembrane domain. A FLAG tag fused to the NH<s...
<p>HepG2 cells were pretreated with DMSO alone or DMSO containing Cpd3 (panel A), Cpd188 (panel B), ...
(A) AGS cells were incubated with or without LiCl (20 mM) or SB (25 μM) for 24 hours. Western blot a...
<p><b>A, Top,</b> Left panel: Cell survival of Rink-1 cells treated with GSI. Cells treated with GSI...
<p>(<b>A</b>), SCC1 and OSC19 cells were treated with varying concentrations of GSPs (0, 20, 40 and ...
<p>(A) Immunofluorescence analysis of PAX-7 (green) and DAPI (blue) expression in primary satellite ...
<p>Cells were transiently transfected with GSK3-β (S9A), GSK3-β (K85) and pCDNA3.1 as Mock using Fug...
<p><b>A</b>, Proliferation of RD and KYM-1 cells treated with GSI X or equal volume of DMSO vehicle ...
<p>(A-B) IFNγ-primed BMMs were pre-treated with vehicle control DMSO or GSI (25 μM) for 30 min and a...
<p><i>A</i>, BT474 (left) and LNCaP (right) cell lines were treated with DMSO or GSK2110183 for 1 h....
A. Representative western blot of U937 cells treated for 24 hours with the indicated TKIs. B. Quanti...
<p>(A) Wound recovery of U251 and U87 cells in the presence of indicated agents. ** <i>P</i><0.01 ve...
<p>(A) Transduced Ba/F3 cells were treated with DMSO (0.1%) or the indicated concentrations of GSK-3...
<p>Each assay was repeated at least 3 times. The values in the table are the means ± standard errors...
<p>(<b>A</b>), Treatment of HNSCC cells (SCC1, OSC19, FaDu and SCC5) with GSPs for 24 and 48 h inhib...
<p>A. Design of SPP assay substrate based on BRI2 transmembrane domain. A FLAG tag fused to the NH<s...
<p>HepG2 cells were pretreated with DMSO alone or DMSO containing Cpd3 (panel A), Cpd188 (panel B), ...
(A) AGS cells were incubated with or without LiCl (20 mM) or SB (25 μM) for 24 hours. Western blot a...
<p><b>A, Top,</b> Left panel: Cell survival of Rink-1 cells treated with GSI. Cells treated with GSI...
<p>(<b>A</b>), SCC1 and OSC19 cells were treated with varying concentrations of GSPs (0, 20, 40 and ...
<p>(A) Immunofluorescence analysis of PAX-7 (green) and DAPI (blue) expression in primary satellite ...